Debulking Surgery in Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Malignant Neoplasm of OvaryMalignant Neoplasm of Fallopian TubeMalignant Neoplasm of Peritoneum
Interventions
PROCEDURE

Diagnostic laparoscopy

The patient will initially undergo a diagnostic laparoscopy by a minimally invasive approach and entry method. The decision of which approach and entry to perform will be dictated by the primary surgeon of record's preference and their assessment of pre-operative patient factors. Once the primary surgeon determines the areas of macroscopic disease, he/she will make an assessment as to the need to convert to a laparotomy or continue laparoscopically. At the completion of the procedure, it will be noted whether an optimal cytoreduction (≤ 1 cm residual disease) or a sub-optimal cytoreduction (\>1 cm residual disease) was performed.

Trial Locations (2)

28203

Atrium/Charlotte-Mecklenburg Hospital Authority, Charlotte

44195

Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT03378128 - Debulking Surgery in Ovarian Cancer | Biotech Hunter | Biotech Hunter